- CA$7.76m
- CA$4.22m
- CA$5.07m
- 55
- 60
- 35
- 48
2019 October 31st | 2020 October 31st | 2021 October 31st | 2022 October 31st | 2023 October 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 5.61 | 5.44 | 4.12 | 3.9 | 5.07 |
Cost of Revenue | |||||
Gross Profit | 0.783 | 1.28 | -0.008 | 0.531 | 0.394 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 11.1 | 13 | 10.8 | 25.2 | 13.2 |
Operating Profit | -5.53 | -7.58 | -6.64 | -21.3 | -8.16 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -6.81 | -7.43 | -7.1 | -21 | -7.71 |
Provision for Income Taxes | |||||
Net Income After Taxes | -6.82 | -7.43 | -7.11 | -21 | -7.72 |
Net Income Before Extraordinary Items | |||||
Net Income | -6.82 | -7.43 | -7.11 | -21 | -7.72 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -6.82 | -7.43 | -7.11 | -21 | -7.72 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.044 | -0.074 | -0.066 | -0.1 | -0.058 |
Dividends per Share |